View in EDS

A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.

Saved in:
Bibliographic Details
Title: A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
Authors: Dampier CD; Department of Pediatrics, Emory University, Atlanta, GA.; Aflac Cancer and Blood Disorders Center, Atlanta, GA.; Children's Healthcare of Atlanta, Atlanta, GA., Telen MJ; Division of Hematology, Duke Comprehensive Sickle Cell Center, Duke University Medical Center, Durham, NC., Wun T; Division of Hematology Oncology, UC Davis School of Medicine, Sacramento, CA., Brown RC; Department of Pediatrics, Emory University, Atlanta, GA.; Aflac Cancer and Blood Disorders Center, Atlanta, GA.; Children's Healthcare of Atlanta, Atlanta, GA., Desai P; James Comprehensive Cancer Hospital & Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH., El Rassi F; Georgia Comprehensive Sickle Cell Center and Grady Health System, Atlanta, GA.; Department of Medicine, Emory University, Atlanta, GA., Fuh B; East Carolina University Comprehensive Sickle Cell Center, Greenville, NC., Kanter J; Department of Medicine, University of Alabama, Birmingham, AL., Pastore Y; CHU Sainte-Justine, Montreal, QC, Canada.; Department of Pediatrics, University of Montreal, Montreal, QC, Canada., Rothman J; Division of Pediatric Hematology/Oncology, Duke University Medical Center, Durham, NC., Taylor JG; Center for Sickle Cell Disease, Howard University College of Medicine, Washington, DC., Readett D; Pfizer Inc, Collegeville, PA., Sivamurthy KM; Pfizer Inc, Collegeville, PA., Tammara B; Pfizer Inc, Collegeville, PA., Tseng LJ; Pfizer Inc, New York, NY., Lozier JN; GlycoMimetics Inc, Rockville, MD., Thackray H; GlycoMimetics Inc, Rockville, MD., Magnani JL; GlycoMimetics Inc, Rockville, MD., Hassell KL; Division of Hematology, University of Colorado, Aurora, CO.
Corporate Authors: RESET Investigators
Source: Blood [Blood] 2023 Jan 12; Vol. 141 (2), pp. 168-179.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35981565
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dampier+CD%22">Dampier CD</searchLink>; Department of Pediatrics, Emory University, Atlanta, GA.; Aflac Cancer and Blood Disorders Center, Atlanta, GA.; Children's Healthcare of Atlanta, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Telen+MJ%22">Telen MJ</searchLink>; Division of Hematology, Duke Comprehensive Sickle Cell Center, Duke University Medical Center, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Wun+T%22">Wun T</searchLink>; Division of Hematology Oncology, UC Davis School of Medicine, Sacramento, CA.<br /><searchLink fieldCode="AU" term="%22Brown+RC%22">Brown RC</searchLink>; Department of Pediatrics, Emory University, Atlanta, GA.; Aflac Cancer and Blood Disorders Center, Atlanta, GA.; Children's Healthcare of Atlanta, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Desai+P%22">Desai P</searchLink>; James Comprehensive Cancer Hospital & Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22El+Rassi+F%22">El Rassi F</searchLink>; Georgia Comprehensive Sickle Cell Center and Grady Health System, Atlanta, GA.; Department of Medicine, Emory University, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Fuh+B%22">Fuh B</searchLink>; East Carolina University Comprehensive Sickle Cell Center, Greenville, NC.<br /><searchLink fieldCode="AU" term="%22Kanter+J%22">Kanter J</searchLink>; Department of Medicine, University of Alabama, Birmingham, AL.<br /><searchLink fieldCode="AU" term="%22Pastore+Y%22">Pastore Y</searchLink>; CHU Sainte-Justine, Montreal, QC, Canada.; Department of Pediatrics, University of Montreal, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Rothman+J%22">Rothman J</searchLink>; Division of Pediatric Hematology/Oncology, Duke University Medical Center, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Taylor+JG%22">Taylor JG</searchLink>; Center for Sickle Cell Disease, Howard University College of Medicine, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Readett+D%22">Readett D</searchLink>; Pfizer Inc, Collegeville, PA.<br /><searchLink fieldCode="AU" term="%22Sivamurthy+KM%22">Sivamurthy KM</searchLink>; Pfizer Inc, Collegeville, PA.<br /><searchLink fieldCode="AU" term="%22Tammara+B%22">Tammara B</searchLink>; Pfizer Inc, Collegeville, PA.<br /><searchLink fieldCode="AU" term="%22Tseng+LJ%22">Tseng LJ</searchLink>; Pfizer Inc, New York, NY.<br /><searchLink fieldCode="AU" term="%22Lozier+JN%22">Lozier JN</searchLink>; GlycoMimetics Inc, Rockville, MD.<br /><searchLink fieldCode="AU" term="%22Thackray+H%22">Thackray H</searchLink>; GlycoMimetics Inc, Rockville, MD.<br /><searchLink fieldCode="AU" term="%22Magnani+JL%22">Magnani JL</searchLink>; GlycoMimetics Inc, Rockville, MD.<br /><searchLink fieldCode="AU" term="%22Hassell+KL%22">Hassell KL</searchLink>; Division of Hematology, University of Colorado, Aurora, CO.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22RESET+Investigators%22">RESET Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2023 Jan 12; Vol. 141 (2), pp. 168-179.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35981565
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2022015797
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 168
    Titles:
      – TitleFull: A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dampier CD
      – PersonEntity:
          Name:
            NameFull: Telen MJ
      – PersonEntity:
          Name:
            NameFull: Wun T
      – PersonEntity:
          Name:
            NameFull: Brown RC
      – PersonEntity:
          Name:
            NameFull: Desai P
      – PersonEntity:
          Name:
            NameFull: El Rassi F
      – PersonEntity:
          Name:
            NameFull: Fuh B
      – PersonEntity:
          Name:
            NameFull: Kanter J
      – PersonEntity:
          Name:
            NameFull: Pastore Y
      – PersonEntity:
          Name:
            NameFull: Rothman J
      – PersonEntity:
          Name:
            NameFull: Taylor JG
      – PersonEntity:
          Name:
            NameFull: Readett D
      – PersonEntity:
          Name:
            NameFull: Sivamurthy KM
      – PersonEntity:
          Name:
            NameFull: Tammara B
      – PersonEntity:
          Name:
            NameFull: Tseng LJ
      – PersonEntity:
          Name:
            NameFull: Lozier JN
      – PersonEntity:
          Name:
            NameFull: Thackray H
      – PersonEntity:
          Name:
            NameFull: Magnani JL
      – PersonEntity:
          Name:
            NameFull: Hassell KL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 01
              Text: 2023 Jan 12
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 141
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1